228 related articles for article (PubMed ID: 26266098)
1. Oligometastatic disease, the curative challenge in radiation oncology.
Palacios-Eito A; García-Cabezas S
World J Clin Oncol; 2015 Aug; 6(4):30-4. PubMed ID: 26266098
[TBL] [Abstract][Full Text] [Related]
2. The role of radiation therapy in the modern management of oligometastatic disease.
Li Y; Tao S; Li M; Li D
J BUON; 2017; 22(4):831-837. PubMed ID: 29155507
[TBL] [Abstract][Full Text] [Related]
3. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
4. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.
Guerrero E; Ahmed M
Lung Cancer; 2016 Feb; 92():22-8. PubMed ID: 26775592
[TBL] [Abstract][Full Text] [Related]
5. Oligometastases in prostate cancer: Ablative treatment.
Palacios-Eito A; Béjar-Luque A; Rodríguez-Liñán M; García-Cabezas S
World J Clin Oncol; 2019 Feb; 10(2):38-51. PubMed ID: 30815370
[TBL] [Abstract][Full Text] [Related]
6. SBRT for lung oligometastases: Who is the perfect candidate?
Navarria P; De Rose F; Ascolese AM
Rep Pract Oncol Radiother; 2015; 20(6):446-53. PubMed ID: 26696785
[TBL] [Abstract][Full Text] [Related]
7. Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.
Wild AT; Yamada Y
Visc Med; 2017 Mar; 33(1):54-61. PubMed ID: 28612018
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
9. The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review.
Turchan WT; Chmura SJ
Ann Palliat Med; 2021 May; 10(5):6028-6044. PubMed ID: 33440982
[TBL] [Abstract][Full Text] [Related]
10. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
Niazi T; Elakshar S; Stroian G
Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
12. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Juan O; Popat S
Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
[TBL] [Abstract][Full Text] [Related]
13. Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer.
Wada Y; Hashimoto M
Transl Cancer Res; 2020 Aug; 9(8):5077-5086. PubMed ID: 35117873
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
[TBL] [Abstract][Full Text] [Related]
16. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
Palma DA; Olson R; Harrow S; Correa RJM; Schneiders F; Haasbeek CJA; Rodrigues GB; Lock M; Yaremko BP; Bauman GS; Ahmad B; Schellenberg D; Liu M; Gaede S; Laba J; Mulroy L; Senthi S; Louie AV; Swaminath A; Chalmers A; Warner A; Slotman BJ; de Gruijl TD; Allan A; Senan S
BMC Cancer; 2019 Aug; 19(1):816. PubMed ID: 31426760
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
